CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 91 filers reported holding CUE BIOPHARMA INC in Q3 2021. The put-call ratio across all filers is 0.43 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $28 | -70.2% | 11,984 | -53.4% | 0.00% | – |
| Q2 2023 | $94 | -90.6% | 25,700 | +9279.6% | 0.00% | – |
| Q2 2022 | $1,000 | -98.9% | 274 | -98.5% | 0.00% | – |
| Q1 2022 | $89,000 | -56.6% | 18,211 | +0.3% | 0.00% | – |
| Q4 2021 | $205,000 | -22.9% | 18,152 | -0.4% | 0.00% | – |
| Q3 2021 | $266,000 | -11.0% | 18,229 | -28.9% | 0.00% | – |
| Q2 2021 | $299,000 | -3.5% | 25,642 | +1.0% | 0.00% | – |
| Q1 2021 | $310,000 | -2.5% | 25,400 | 0.0% | 0.00% | – |
| Q4 2020 | $318,000 | -16.8% | 25,400 | 0.0% | 0.00% | – |
| Q3 2020 | $382,000 | -38.7% | 25,400 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $623,000 | +133.3% | 25,400 | +35.1% | 0.00% | – |
| Q1 2020 | $267,000 | -10.4% | 18,800 | 0.0% | 0.00% | – |
| Q4 2019 | $298,000 | +227.5% | 18,800 | +74.1% | 0.00% | – |
| Q3 2019 | $91,000 | -6.2% | 10,800 | 0.0% | 0.00% | – |
| Q2 2019 | $97,000 | +304.2% | 10,800 | +248.4% | 0.00% | – |
| Q1 2019 | $24,000 | +60.0% | 3,100 | 0.0% | 0.00% | – |
| Q4 2018 | $15,000 | -91.6% | 3,100 | -84.3% | 0.00% | – |
| Q3 2018 | $178,000 | -23.9% | 19,700 | 0.0% | 0.00% | – |
| Q2 2018 | $234,000 | – | 19,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,510,282 | $7,370,000 | 4.76% |
| SANDERS MORRIS HARRIS LLC | 873,021 | $4,261,000 | 0.83% |
| P.A.W. CAPITAL CORP | 150,000 | $732,000 | 0.76% |
| Nantahala Capital Management | 2,244,359 | $10,952,000 | 0.48% |
| Bleichroeder LP | 552,000 | $2,694,000 | 0.48% |
| APOGEM CAPITAL LLC | 111,259 | $543,000 | 0.37% |
| Slate Path Capital LP | 1,483,619 | $7,240,000 | 0.37% |
| Robertson Stephens Wealth Management, LLC | 478,500 | $2,335,000 | 0.20% |
| CARLSON CAPITAL L P | 405,000 | $1,976,000 | 0.14% |
| Bridgefront Capital, LLC | 19,968 | $97,000 | 0.12% |